These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4559279)

  • 1. [Treatment of vegetative cardio-circulatory disorders using beta receptor blockaders. Double blind study on Pindolol-Visken].
    Engel HJ
    Med Welt; 1972 Jul; 23(27):980-4. PubMed ID: 4559279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial using the beta receptor blockader Visken].
    Szám I; Holló J
    Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 5. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 6. [Decrease in ventricular frequency in auricular fibrillation using Visken].
    Bender F; Dürholz HH; Gradaus D; Schmidt E
    Med Welt; 1971 Feb; 9():340-1. PubMed ID: 4396541
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of neurocirculatory asthenia using beta-receptor blocking agents].
    Schweitzer P; Klvánová H; Blasková B; Turcsányi L
    Cas Lek Cesk; 1968 Feb; 107(8):242-3. PubMed ID: 5664794
    [No Abstract]   [Full Text] [Related]  

  • 9. A double blind trial of LB-46 in the treatment of angina pectoris.
    Raychaudhuri B; Das MR; Neelakatan C; Chaudhuri ND; Bose J; Chetri MK
    Indian Heart J; 1973 Jan; 25(1):58-61. PubMed ID: 4576304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychopharmacologic treatment of cardiac neurotic patients with dipotassium chlorazepate in double-blind test].
    Schüffel W; Schaumburg C; Schäfer N
    Arzneimittelforschung; 1970 Jan; 20(1):127-30. PubMed ID: 4909438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
    Maranhão MF; da Cunha GP; Rojas RI
    Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of angina pectoris with beta receptor blockaders].
    Kaltenbach M; Becker HJ; Graef V; Hunscha H
    Med Klin; 1971 Mar; 65(11):494-500. PubMed ID: 4996983
    [No Abstract]   [Full Text] [Related]  

  • 14. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
    Nestel PJ
    Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-adrenergic-receptor blockade in the treatment of anxiety.
    Tyrer P; Lader M
    Lancet; 1972 Sep; 2(7776):542. PubMed ID: 4115598
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
    Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxprenolol in Parkinson's disease.
    Jackson R; Crawford CO; Peel JS
    N Z Med J; 1971 Oct; 74(473):246-7. PubMed ID: 4399810
    [No Abstract]   [Full Text] [Related]  

  • 18. Prindolol in hypertension.
    Thorpe P
    Med J Aust; 1971 Jun; 1(23):1242. PubMed ID: 5567222
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)].
    Guardigli R
    Minerva Cardioangiol; 1970 Feb; 18(2):131-40. PubMed ID: 4393800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of functional disorders of the cardiovascular system with a new benzodiazepine preparation].
    Matteoli E; Lampugnani E; Zaini G; Riva D
    Minerva Med; 1974 Jun; 65(45):2481-4. PubMed ID: 4602654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.